Related Experiment Video
Updated: Jul 12, 2025
12:42
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
9.5K
Engineering Non-Human RNA Viruses for Cancer Therapy
Vicent Tur-Planells1, Adolfo García-Sastre2,3,4,5,6, Sara Cuadrado-Castano2,7,8
1Microbiology Section, Department of Pharmaceutical Science and Health, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, 28668 Boadilla del Monte, Spain.
Vaccines
|October 28, 2023
Summary
Oncolytic viruses (OVs) are evolving beyond simple cell killing, with engineered RNA viruses showing promise in cancer immunotherapy by stimulating the immune system. Research highlights novel strategies for optimizing these viral platforms for enhanced cancer treatment.
Area of Science:
- Oncology
- Virology
- Immunotherapy
Background:
- Cancer immunotherapy is rapidly advancing, with oncolytic viruses (OVs) emerging as a key therapeutic strategy.
- Clinical trials involving OVs have increased significantly, expanding their therapeutic applications.
- Current research moves beyond the traditional 'lytic killer' concept towards leveraging viral immunostimulatory potential.
Purpose of the Study:
- To review engineered non-human-adapted RNA viruses for cancer therapy.
- To describe genome manipulation strategies for optimizing OV therapeutic capabilities.
- To provide insights into advancements in virotherapy for cancer treatment.
Main Methods:
- Literature review of engineered non-human-adapted RNA viruses.
- Analysis of viral genome engineering strategies for cancer therapy.
- Synthesis of current research on virotherapy advancements.
Main Results:
- Engineered RNA viruses offer novel approaches in cancer immunotherapy.
- Genome modifications enhance the therapeutic efficacy of oncolytic viruses.
- Virotherapy demonstrates significant potential to revolutionize cancer treatment.
Conclusions:
- Oncolytic RNA viruses represent a promising frontier in cancer treatment.
- Strategic genetic engineering unlocks new therapeutic potentials for virotherapy.
- The field of virotherapy is poised for significant advancements in oncology.
Related Concept Videos
02:30siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
01:51Mechanisms of Retrovirus-induced Cancers
5.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K
01:23RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K
02:15Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
01:29Viruses with RNA Genomes
35
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
35